PHA Classroom banner

PHA Classroom has moved! Visit

>> Back to Recordings
Session Recording from PHA's 2010 9th International PH Conference

PAH Drug Development: The Pipeline Runneth Over

June 27, 2010

There are now eight approved PAH drugs in the U.S., several of which are available in multiple formulations. At least eight more drugs are currently in development. During this session, we will discuss how the newer drugs will impact drug selection for an individual patient.

Session Handout (PDF)

The below recording will begin automatically. To view the controls, move your mouse anywhere over the video then move to the control interface at the bottom of the video.



Presenter Information

Kamal Mubarak, MD, University of Florida, Gainesville, Fla. (Chair)  
Cheryl Abbott, RN, University of Colorado Denver, Aurora, Colo.
Michael Mathier, MD, University of Pittsburgh, Pittsburgh, Penn.

>>If you liked this recording, you may enjoy Stem Cells and PAH: Cause or Cure?

Stem Cells and PAH: Cause or Cure?





Actelion Pharmaceuticals US, Inc. Gilead Sciences, Inc. Bayer HealthCare United Therapeutics Corporation
This is a program of the PHA Medical Education Fund, made possible through unrestricted educational grants from our supporters.


FacebookTwitterInstagram iconLinkedInYouTube

For optimal viewing of, please use a standards-compliant browser such as Google Chrome or Firefox.

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
    Privacy Policy    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.® | © 2016 Pulmonary Hypertension Association. All Rights Reserved.


The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.